Management of hepatitis C in patients with chronic kidney disease

被引:0
|
作者
Roberto J Carvalho-Filho [1 ]
Ana Cristina CA Feldner [1 ]
Antonio Eduardo B Silva [1 ]
Maria Lucia G Ferraz [1 ]
机构
[1] Division of Gastroenterology,Hepatology Section,Federal University of Sao Paulo,Sao Paulo,SP 04023-900,Brazil
关键词
Hepatitis C virus; Chronic kidney disease; End-stage renal disease; Hemodialysis; Kidney transplantation; Diagnosis; Conservative management; Therapy;
D O I
暂无
中图分类号
R692 [肾疾病]; R512.63 [];
学科分类号
1002 ; 100210 ; 100401 ;
摘要
Hepatitis C virus(HCV) infection is highly prevalent among chronic kidney disease(CKD) subjects under hemodialysis and in kidney transplantation(KT) recipients, being an important cause of morbidity and mortality in these patients. The vast majority of HCV chronic infections in the hemodialysis setting are currently attributable to nosocomial transmission. Acute and chronic hepatitis C exhibits distinct clinical and laboratorial features, which can impact on managementand treatment decisions. In hemodialysis subjects, acute infections are usually asymptomatic and anicteric; since spontaneous viral clearance is very uncommon in this context, acute infections should be treated as soon as possible. In KT recipients, the occurrence of acute hepatitis C can have a more severe course, with a rapid progression of liver fibrosis. In these patients, it is recommended to use pegylated interferon(PEG-IFN) in combination with ribavirin, with doses adjusted according to estimated glomerular filtration rate. There is no evidence suggesting that chronic hepatitis C exhibits a more aggressive course in CKD subjects under conservative management. In these subjects, indication of treatment with PEG-IFN plus ribavirin relies on the CKD stage, rate of progression of renal dysfunction and the possibility of a preemptive transplant. HCV infection has been associated with both liver disease-related deaths and cardiovascular mortality in hemodialysis patients. Among those individuals, low HCV viral loads and the phenomenon of intermittent HCV viremia are often observed, and sequential HCV RNA monitoring is needed. Despite the poor tolerability and suboptimal efficacy of antiviral therapy in CKD patients, many patients can achieve sustained virological response, which improve patient and graft outcomes. Hepatitis C eradication before KT theoretically improves survival and reduces the occurrence of chronic graft nephropathy, de novo glomerulonephritis and post-transplant diabetes mellitus.
引用
收藏
页码:408 / 422
页数:15
相关论文
共 50 条
  • [21] Hepatitis C Treatment in Chronic Kidney Disease Patients: The Kidney Disease Improving Global Outcomes Perspective
    Jadoul, Michel
    Martin, Paul
    [J]. BLOOD PURIFICATION, 2017, 43 (1-3) : 206 - 209
  • [22] Hepatitis B and hepatitis C virus and chronic kidney disease
    Fabrizi, F.
    Martin, P.
    Messa, P.
    [J]. ACTA GASTRO-ENTEROLOGICA BELGICA, 2010, 73 (04) : 465 - 471
  • [23] RIBAVIRIN THERAPEUTIC DRUG MONITORING IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HEPATITIS C
    Roberts, D.
    Ray, J.
    Furlong, T.
    [J]. NEPHROLOGY, 2010, 15 : 76 - 76
  • [24] Hepatitis C Increases the Risk of Progression of Chronic Kidney Disease in Patients with Glomerulonephritis
    Noureddine, Lama A.
    Usman, Sohail A.
    Yu, Zhangsheng
    Moorthi, Ranjani N.
    Moe, Sharon M.
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2010, 32 (04) : 311 - 316
  • [25] Management of patients with chronic kidney disease
    Gerntholtz, T.
    Paget, G.
    Hsu, P.
    Meyers, A. M.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2015, 105 (03): : 237
  • [26] Management of patients with chronic kidney disease
    Francesco P. Schena
    [J]. Internal and Emergency Medicine, 2011, 6
  • [27] Management of patients with chronic kidney disease
    Schena, Francesco P.
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2011, 6 : 77 - 83
  • [28] Direct-acting antivirals for the treatment of chronic hepatitis C in patients with chronic kidney disease
    Kohli, Anita
    Alshati, Ali
    Georgie, Fawaz
    Manch, Richard
    Gish, Robert G.
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2016, 9 (06): : 887 - 897
  • [29] Treatment of chronic hepatitis C in patients with chronic kidney disease with Sofosbuvir-basead regimes
    Rossato, Giovana
    Tovo, Cristiane Valle
    Lerias de Almeida, Paulo Roberto
    [J]. BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2020, 24 (01): : 25 - 29
  • [30] Hepatitis C Virus Infection in Chronic Kidney Disease
    Ladino, Marco
    Pedraza, Fernando
    Roth, David
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (08): : 2238 - 2246